SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : 10-Bagger MINIMUM Rise from July 1, 2005 until December 31, -- Ignore unavailable to you. Want to Upgrade?


To: Walkingshadow who wrote (796)11/3/2005 6:03:07 PM
From: Jill  Read Replies (1) | Respond to of 1694
 
BTW a long while back we discussed Neutec Pharma, or I brought it up, LSE.NTP London and I'm pretty sure NUTQF.PK here (just checked)

Now I actually think what they're doing is really cool and they are down from their highs because they underestimated costs. They took people who'd gotten well from MRSA, and resistant candida, and made a super-antibody to HSP 90 for mycograb (fungi). Mycograb is farther along than aurograb (staph), and now they're doing clinical trials in cancer because of HSP 90:

Message 21840901

Its basically a totally well tolerated "drug" that is given along with other drugs to increase efficacy.

I still really like this company and idea although I recall you weren't that impressed. Any new thoughts? I never did buy but they still are appealing, esp as I said they're down off their highs.



To: Walkingshadow who wrote (796)11/3/2005 6:05:12 PM
From: rrufff  Respond to of 1694
 
Less of the bitter taste, more natural - or so they say, none of the controversy of saccharin, sorbital, aspertame, etc.